The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
He brings extensive cross-functional expertise built through leadership roles
Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
The agreement will combine Biocytogen’s cutting-edge fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive drug development
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
